Drug profile · INN
pseudoephedrine sulfate
AFRINOL
pseudoephedrine sulfate (AFRINOL) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
Drug details — pseudoephedrine sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pseudoephedrine sulfate (AFRINOL) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter releasing agent
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pseudoephedrine sulfate?
pseudoephedrine sulfate (AFRINOL) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pseudoephedrine sulfate?
AFRINOL is a marketed brand name for pseudoephedrine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pseudoephedrine sulfate?
pseudoephedrine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.